Annual Long Term Debt
$79.47 M
-$3.41 M-4.12%
31 December 2023
Summary:
Poseida Therapeutics annual long term debt is currently $79.47 million, with the most recent change of -$3.41 million (-4.12%) on 31 December 2023. During the last 3 years, it has risen by +$24.96 million (+45.80%). PSTX annual long term debt is now -4.12% below its all-time high of $82.89 million, reached on 31 December 2022.PSTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$76.64 M
-$972.00 K-1.25%
30 September 2024
Summary:
Poseida Therapeutics quarterly long term debt is currently $76.64 million, with the most recent change of -$972.00 thousand (-1.25%) on 30 September 2024. Over the past year, it has dropped by -$3.71 million (-4.62%). PSTX quarterly long term debt is now -10.69% below its all-time high of $85.81 million, reached on 31 March 2022.PSTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.1% | -4.6% |
| 3 y3 years | +45.8% | +40.1% |
| 5 y5 years | +316.4% | - |
PSTX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.1% | +45.8% | -10.7% | +40.1% |
| 5 y | 5 years | -4.1% | +316.4% | -10.7% | +193.2% |
| alltime | all time | -4.1% | +824.4% | -10.7% | +193.2% |
Poseida Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $76.64 M(-1.3%) |
| June 2024 | - | $77.61 M(-1.2%) |
| Mar 2024 | - | $78.57 M(-1.1%) |
| Dec 2023 | $79.47 M(-4.1%) | $79.47 M(-1.1%) |
| Sept 2023 | - | $80.35 M(-1.1%) |
| June 2023 | - | $81.22 M(-1.0%) |
| Mar 2023 | - | $82.07 M(-1.0%) |
| Dec 2022 | $82.89 M(+51.1%) | $82.89 M(-1.2%) |
| Sept 2022 | - | $83.90 M(-1.1%) |
| June 2022 | - | $84.87 M(-1.1%) |
| Mar 2022 | - | $85.81 M(+56.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $54.86 M(+0.6%) | $54.86 M(+0.3%) |
| Sept 2021 | - | $54.70 M(-1.2%) |
| June 2021 | - | $55.36 M(+4.5%) |
| Mar 2021 | - | $52.98 M(-2.8%) |
| Dec 2020 | $54.51 M(+108.5%) | $54.51 M(-0.3%) |
| Sept 2020 | - | $54.67 M(+9.0%) |
| June 2020 | - | $50.18 M(+12.1%) |
| Mar 2020 | - | $44.74 M(+71.2%) |
| Dec 2019 | $26.14 M(+37.0%) | $26.14 M |
| Dec 2018 | $19.09 M(+122.0%) | - |
| Dec 2017 | $8.60 M | - |
FAQ
- What is Poseida Therapeutics annual long term debt?
- What is the all time high annual long term debt for Poseida Therapeutics?
- What is Poseida Therapeutics annual long term debt year-on-year change?
- What is Poseida Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly long term debt year-on-year change?
What is Poseida Therapeutics annual long term debt?
The current annual long term debt of PSTX is $79.47 M
What is the all time high annual long term debt for Poseida Therapeutics?
Poseida Therapeutics all-time high annual long term debt is $82.89 M
What is Poseida Therapeutics annual long term debt year-on-year change?
Over the past year, PSTX annual long term debt has changed by -$3.41 M (-4.12%)
What is Poseida Therapeutics quarterly long term debt?
The current quarterly long term debt of PSTX is $76.64 M
What is the all time high quarterly long term debt for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly long term debt is $85.81 M
What is Poseida Therapeutics quarterly long term debt year-on-year change?
Over the past year, PSTX quarterly long term debt has changed by -$3.71 M (-4.62%)